From Sarah's CV
Providing businesses the skills to make that next step with a highly motivated, engaged and effective team following a bespoke strategy.
Expert in training and coaching particularly for developing and established sales teams; and 1:1 coaching for peers keen to enhance their skill set.
Proven evidence of:
- recruiting, retaining and developing successful sales teams
- developing market access strategies, product launch & roll out; and how to secure government reimbursement
- developing future Senior Managers from internal talent pool
Experienced in the fields of medical devices, manufacturing and catering.
https://www.linkedin.com/in/sarah-humphreys-8b617523/?originalSubdomain=ukSarah Humphreys
Sarah Humphreys
Experienced Commercial Sales Leader and Coach
BabyHuey, I must be making it up then, do you really think I'd go to the effort of posting something that wasn't true. The text message received from Barclays at 1630 Friday advising that my order had 'been completed' must be wrong too.
BabyHuey, Have no idea how it would appear, however the 7700 SELL was the last trade before the close, although it was my BUY going through. The limit order that I had placed was for 165p, however executed at <164p (Barclays).
DRB83, Totally agree, however the UK is our largest single marker and I'd imagine the biggest market for ProMate, therefore the most important market for Co-Prep. They cannot launch Co-Prep until Pro-Mate's future is assured via CTDA approval.
Once the dispute is finally resolved, don't expect any specific detail or explanation as to the true nature of the issue.
My biggest concern at present is the CTDA validations, why is it taking so long? Also, I firmly believe that this is the reason as to why Co-Prep has not been launched, the company perhaps taking the view that whilst Pro-Mate is listed upon the Temporary Protocol, there was a risk launching Co-Prep, which is designed to work with Pro-Mate, the risk being that come the end of Feb Pro-Mate has to be withdrawn from sale within the UK, therefore no product to work with Co-Prep. I'd imagine that the UK is likely to be the initial market for Co-Prep.
"It is has acquired and instrument arm to add to its testing capability"
Worth pointing out that the cash paid to acquire IT-IS International is equal to Today's Enterprise value for Novacyt of £10m. The market could not value a **** up in a brewery!
Work that one out, because I'm struggling!!
Hardly the best time to relax restrictions.
https://twitter.com/drajm/status/1488155705291214850
If omicron was mild it would not be causing Paediatric hospital admissions in Europe & England THREE times higher than seen during the Jan 2021 winter peak.
Over the weekend I speculated that Co-prep had possibly been cancelled as part of David Allmond's review, having been in contact with the company, Novacyt have confirmed that this is not the case and that 'Co-prep is still to be launched.'